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Abstract
Background—Dichlorodiphenyltrichloroethane (DDT) is an organo-chlorine pesticide still used
in areas of the world where malaria vector control is needed. Few studies have examined in utero
exposures to DDT in relation to fetal and early childhood growth in populations with substantial
exposure to DDT. Furthermore, only a portion of these studies have investigated in utero
exposures and growth during childhood.
Methods—To assess the role of in utero exposures to DDT on fetal and early childhood growth,
we analyzed data from mothers and children who participated in the Child Health and
Development Study (CHDS), a cohort study of 20,754 women and their pregnancies conducted in
the San Francisco Bay area during the 1960s. We measured p,p′-DDE, o,p′-DDT, and p,p′-DDT
concentrations from the stored sera of 399 women collected during pregnancy. Outcomes were
measured at the child’s birth and at 5 years of age.
Results—Maternal p,p′-DDE concentrations were considerable in this study, averaging 6.9
micrograms per gram lipid. After covariate adjustment, a small increase in gestational age was
observed with increases in p,p′-DDT and o,p′-DDT, but there was no association with p,p′-DDE.
At 5 years of age, an increase from the 25th to the 75th percentile in p,p′-DDE was related to a 2-
mm increase in head circumference (95% confidence interval = 0 to 4). Overall effect sizes were
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small and imprecise. Furthermore, there was little evidence of specificity for a given outcome or
exposure at either age.
Conclusions—At the concentrations studied in this sample, DDT compounds did not appear to
impair fetal or 5-year growth.
Dichlorodiphenyltrichloroethane (DDT) was used widely in the United States as a pesticide
until its ban in 1973. Its use was also restricted by most industrialized countries in the 1970s;
however, use continues in countries where malaria vector control is still needed. Technical-
grade DDT is composed almost entirely of 2 isomers, p,p′-DDT and o,p′-DDT.1
Dichlorodiphenyldichloroethene (DDE) isomers p,p′-DDE and o,p′-DDE result from DDT
that has either degraded in the environment or has been metabolized. Because of their
chemical stability and water insolubility, some DDT compounds persist in the environment
years after their application, bioaccumulating through the food chain.2 As a result, humans
are generally exposed to DDT compounds through consumption of meats, poultry, dairy
products, and fish, and during breast-feeding as infants.3–5 Moreover, studies have
demonstrated that maternal concentrations of DDT are transmitted to the developing fetus
through the placenta6 and that blood concentrations of DDT in infants are associated with
maternal levels during pregnancy.7
Animal studies have provided evidence of specific effects and mechanisms for the action of
DDT.1 p,p′-DDE and p,p′-DDT have been demonstrated to inhibit androgen binding to the
androgen receptor, whereas o,p′-DDT binds to the estrogen receptor and induces estrogenic
effects.8 Studies of pregnant rabbits given p,p′-DDT during early gestation show increases in
premature delivery9 and lower birth weights among offspring.10 Furthermore, evidence from
observational studies of wildlife shows an association between increased DDT
concentrations and premature births among California sea lions.11
Despite some data from experimental and wildlife studies, relatively few cohort studies in
humans have examined the potential effects of DDT on fetal growth.12 Among 2380
American infants born between 1959 and 1966, higher concentrations of p,p′-DDE in
maternal serum were associated with an increased risk of preterm delivery as well as with
small-for-gestational-age birth.13 Results from other, later-born cohorts have not
demonstrated associations between DDT and fetal growth, perhaps owing to the sharp
decline in human DDT levels since the 1970s14 as suggested by Gladen and colleagues.15
Additionally, results from case–control studies of preterm birth and fetal growth are mixed,
although these studies were limited in size and some did not account for potential
confounding factors.16–22 Furthermore, previous studies of DDT exposures and postnatal
growth have focused on growth during infancy23 or puberty24,25 but have generally not
considered growth during early childhood. One study of early childhood growth26 relied on
DDT concentrations measured at 8 years of age, rather than at birth, and thus exposure to
DDT compounds was measured subsequent to early childhood growth.
The current study was designed to examine fetal and 5-year growth in relation to prenatal
DDT exposure. Pregnancies in this study occurred during a time of peak DDT use in the
United States,1 making this population ideal for studying the potential effects of in utero
exposure on fetal and early childhood growth.
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This investigation concerns a subsample of mother–child pairs from the Child Health and
Development Study (CHDS), a large prospective cohort study of women who were pregnant
during the 1960s and their children.27,28 Subjects had been recruited through the Kaiser
Foundation Health Plan, a prepaid health system that provides comprehensive medical care
to members throughout California. Members of the Kaiser Health Plan residing in the East
Bay of the San Francisco Bay Area were enrolled in the study when they first contacted
participating Kaiser facilities regarding a confirmed or possible pregnancy. Only those
women who completed their study interview, laboratory work, and sought prenatal care at
participating Kaiser facilities were included in the study.27 In total, 20,754 pregnancies were
enrolled, resulting in 19,044 live births. At the time of the 5-year follow up, 17,045 mother–
child pairs were still under observation.
To select participants for the current study, we first restricted the total CHDS sample to the
3412 children who were selected for and underwent an extensive physical examination at 5
years of age. By CHDS design, these children had to have resided in the San Francisco Bay
area at the time of the 5-year assessment and had to have been born between April 1964 and
April 1967.
From the 3412 children assessed at 5 years of age, we excluded women who were unmarried
minors at the time of their child’s birth or whose enrollment interview was incomplete or
completed after delivery (n = 587). Next, we excluded pregnancies from which a second- or
third-trimester blood specimen was not drawn or an insufficient volume was available (n =
177). Pregnancies with multiple births were also excluded (n = 28). Because we were also
interested in examining cognitive outcomes and potential hypothyroid effects in this sample,
we further excluded the following groups: children with severe abnormalities and those who
did not complete 2 cognitive examinations, a hearing examination, and a speech/language
assessment (n = 227); mothers who were deaf, had rubella during pregnancy, were taking
thyroid medication in the 60 days before blood draw, or who took iodine-containing
medication during pregnancy or in the 6 months before conception (n = 141); and infants
born earlier than 35 weeks or greater than 45 weeks of gestation or for whom gestational age
was unknown (n = 99). When mothers (n = 57) had more than one eligible child, no more
than one was randomly selected. We then selected participants residing in a limited group of
counties to enable a more complete follow-up of the adults, resulting in the exclusion of 805
children.
After these exclusions, there remained 1291 eligible children. From these, we sampled all
children whose standardized score on the Raven’s Progressive Matrices or Pea-body Picture
Vocabulary Test was below the 10th percentile or who failed a hearing examination (stratum
n = 304). From the remaining 987 children who scored above the 10th percentile on both
examinations and passed the hearing screening, approximately 17% were randomly chosen
(stratum n = 175). The current sample is thus a pooled sample of these 2 strata. This
sampling procedure was done to enhance the power for the hypotheses related to
neurobehavioral deficits29 (which were of relatively low prevalence) while not adversely
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affecting efficiency for other hypotheses,30 including those related to growth, the subject of
this article. Of the 479 mother–child pairs selected, serum DDT and lipid concentrations
were determined for 399 of the mothers. Major reasons DDT and lipid concentrations could
not be determined were insufficient volume, breakage, and laboratory error.
Measurement and Analysis of Blood Samples
Approximately 30 mL of blood was drawn from women during pregnancy. Samples were
then centrifuged and the sera aliquoted and stored at −20°C at National Institutes of Health
(NIH) facilities. A subset (those born 1 April 1966 or later) were stored locally and then
shipped to NIH. Blood draws selected for this study occurred between 3.4 and 9.3 months
gestation for all women. The 10th, 25th, 50th, 75th, and 90th percentiles for gestational age
of blood draws were: 4.1, 4.9, 5.6, 6.2, and 7.4 months, respectively.
For the current study, specimens were thawed, aliquoted, frozen, and sent to the University
of California, Davis on dry ice for organochlorine determination. From the original serum
samples, 1.00 mL was made available for the lipid and organochlorine analyses in the
current study. Briefly, serum specimens were analyzed by gas chromatography (Hewlett-
Packard, Palo Alto, CA) with electron capture detection using an RTX-5MS and an
RTX-1701 column.31,32 Concentrations of o,p′-DDE, p,p′-DDE, o,p′-DDT, and p,p′-DDT
were determined. All samples were analyzed between 14 January 1998 and 22 September
1999 in batches of 10 to 20 samples on 25 different days. Concentrations were adjusted for
percent recovery for each sample. Specimens analyzed on batch dates with extremely high
or low variability were reanalyzed and the 2 values averaged. Within-batch coefficients of
variation (CVs) were calculated for each measure of DDT. For comparability with another
study that used specimens from the CHDS,33 we first calculated the CV using the standard
formula in which the standard deviation of each replicate pair was divided by the mean of
each replicate pair and the median value across all replicate pairs was taken as an overall
measure of precision. Calculated this way, the CV was 5.6% for p,p′-DDE, 5.0% for p,p′-
DDT, and 11.1% for o,p′-DDT. However, when the standard deviation of each replicate is
not independent of its mean, Rosner34 suggests log-transforming all values and estimating
the within-subject mean square through a one-way random-effects analysis of variance. The
square root of this value gives the CV on the original, untransformed scale. Calculated in
this way, the CV was 26.9% for p,p′-DDT, 22.6% for p,p′-DDT, and 36.7% for o,p′-DDT.
Values below the limit of quantification (LOQ) (one value for p,p′-DDE and 8 values for o,p
′-DDT) were imputed as described previously.32 o,p′-DDE coeluted during analysis and
could not be quantified.32 Consequently, total DDT (Σ DDT) was calculated by summing
p,p′-DDE, p,p′-DDT, and o,p′-DDT.
Additionally, lipid levels were measured to allow estimation of organochlorines on a per-
lipid basis. Triglycerides and total cholesterol were measured using standard enzymatic
techniques.35–37 Total lipid levels were estimated using the following formula: total lipids =
(2.27 × total cholesterol) + triglyceride + 0.623.38
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Fetal outcomes included birth weight, gestational age, birth length, head circumference, and
gestational age-adjusted birth weight. Gestational age at delivery was calculated by
subtracting the date of the last menstrual period reported by the mother from the date of
delivery in the medical chart. If month of last menstrual period was known but day was not,
maternal reports of the “beginning of the month” were coded as the 7th of the month, the
“end of the month” as the 23rd, and no day information as the 15th of the month. Adjusted
birth weight was expressed as a z-score representing the deviation from mean birth weights
among all U.S. births in 1989 at each week of gestation, stratified by sex, race, and parity.39
Five-Year Growth
At 5 years of age, a pediatrician conducted an extensive physical examination, which
included anthropometric measures of weight, height, sitting height, biacromial distance
(shoulder breadth), chest breadth (maximum breadth across the rib cage), chest depth
(maximum horizontal depth of the chest at the level of the nipples), and bi-iliac distance
(maximum breadth across the iliac crests of the pelvis). Race- and sex-standardized
measures of weight and height were also recorded and are presented as a z-score. Weight
was measured in pounds and ounces, and height and sitting height were measured to the
16th of an inch. Biacromial distance, chest breadth, chest depth, and bi-iliac distance were
measured in millimeters with the Harpenden digital anthropometer.27
Covariates
Mothers were interviewed during pregnancy to collect information about medical and
reproductive history, demographic information about the gravida and her family, and
information about smoking and drinking habits.27 Paternal information was also collected.
Additionally, medical records were abstracted to determine medication use during
pregnancy, previous and chronic illnesses, and whether or not the child was breastfed.
Medications used during pregnancy were reviewed to determine their potential to affect
intrauterine growth. To do this, current references and those appropriate to the time period
of the study were consulted to ascertain each drug’s formulation and active ingredients.40–44
These formulations and ingredients were then checked against current references with regard
to effects on intrauterine growth, and mothers were coded yes/no for medications prescribed
or taken during pregnancy that have been reported to have an association with intrauterine
growth. Twelve medications were identified as potentially disruptive to intrauterine growth.
These medications fell into 4 general categories: tetracycline and derivatives, analgesics,
barbiturates, and amphetamines/central nervous system stimulants. Henceforth these are
referred to as intrauterine growth restriction (IUGR) medications.
From this information, potential covariates for our statistical models were selected based on
known predictors of fetal and early childhood growth. Maternal factors considered as
potential covariates were: age, race/ethnicity, education, occupation, height, prepregnancy
body mass index (BMI), parity, adequacy of prenatal care,45 smoking and alcohol
consumption during pregnancy, IUGR medications used during pregnancy, chronic
hypertension, preeclampsia, and diabetes. Paternal height, occupation, and education were
also considered as potential covariates as was child’s sex.
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Multiple linear regression was used to estimate the association between each measure of
DDT exposure (p,p′-DDE, p,p′-DDT, o,p′-DDT, and Σ DDT) and each outcome where DDT
exposure was modeled continuously as a lipid-adjusted value (in micrograms per gram of
lipid). We developed two sets of covariates, one for the outcomes measured at delivery, and
the other for outcomes at 5 years of age. For each set, we first identified all variables
associated at the P < 0.20 level with any outcome at that age regardless of each variable’s
ultimate association with exposure. Then, to identify the most important confounding
variables, Σ DDT was added to a regression model for each outcome and each covariate
tested to determine whether its exclusion changed the Σ DDT regression coefficient by more
than 10%. If a variable was determined to be a confounder by this criterion, it was included
in all models for that age regardless of the dependent variable. Additionally, all models were
adjusted for the duration of pregnancy at time of blood draw and 2 specimen characteristics:
batch-date of laboratory analysis and an indicator of storage history (only at an NIH facility
or stored on-site and later shipped to the facility).32 Three women with diabetes were
excluded from all fetal growth models. To account for potentially greater homogeneity
within sampling strata, we used the SURVEYREG procedure in SAS (version 9.1; SAS
Institute, Inc., Cary, NC) with design effects to account for the stratified sampling without
replacement; we also applied weights to ensure that our estimates were generalizable to all
children in the CHDS who met the current study’s eligibility criteria. Weights were
proportional to the inverse of the sampling fractions. Sampling weights were 1.27 for the
children whose standardized score on the Raven’s Progressive Matrices or Peabody Picture
Vocabulary Test was below the 10th percentile or who failed a hearing examination and
6.21 for the remaining children who scored above the 10th percentile on both examinations
and passed the hearing test.
Based on previous findings from the literature26,46 and the potential estrogenic effect of o,p
′-DDT and the antian-drogenic effects of p,p′-DDE and p,p′-DDT, we also examined effect
modification by child’s sex by adding a sex*exposure term to each model. A variable
representing the sum of maternal lipid-adjusted polychlorinated biphenyl (PCB) congeners
(IUPAC #105, #110, #118, #137, #138, #153, #170, #180, and #187) was also added to each




Table 1 compares the distributions of maternal, paternal, and child characteristics for
subjects in each sampling stratum and those included in our final sample to those
participating in the original CHDS population. Differences in the distributions of most of the
variables listed in Table 1 can be seen when comparing the 2 sampling strata, thus
motivating the use of weighted regression techniques. Maternal age, parity, prepregnancy
BMI, occupation, education, prenatal care, and smoking status were similar among mothers
in the current study to those participating in the CHDS cohort. Mothers in the current study
were more likely to be black, born in the southeast United States, less likely to consume at
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least one drink per week during pregnancy, less likely to be prescribed medications that
affected intrauterine growth, and slightly more likely to be diagnosed with preeclampsia,
eclampsia, or essential hypertension. Because black race and birth in the Southeast were also
strongly associated with DDT concentration in this sample,32 women participating in the
current study are likely to have higher levels of DDT than mothers in the CHDS not
included in our sample. Compared with the CHDS cohort, fathers in the current study were
less likely to be employed in professional or technical positions or as students and were less
likely to be college graduates.
The mean and median values along with the 25th and 75th percentile of each lipid-adjusted
DDT measure are given in Table 2. As expected, maternal serum concentrations of p,p′-
DDE (the main metabolite of p,p′-DDT) were the highest with a mean approximately 3.5
times that of p,p′-DDT. The distributions of fetal and 5-year growth outcomes are also given
in Table 2.
Fetal Growth
Before adjustment for potential confounders, we observed lower birth weight to be
associated with several of the measures of DDT exposure; the strongest of these was with Σ
DDT(a 58-g reduction in birth weight comparing the 75th with the 25th percentile of Σ
DDT; 95% confidence interval [CI] = −120 to 3). However, none of these associations with
birth weight were statistically significant (data not shown).
Table 3 presents fetal growth results after adjusting for maternal BMI, height, parity, race,
and alcohol intake as well as father’s education and occupation. Overall, there was little
association observed between measures of DDT and fetal growth. Results were inconsistent
with regard to specific exposures or outcomes and effect sizes were small and sometimes
had wide confidence limits. Increases in gestational age were observed for increasing
maternal concentrations of p,p′-DDT and o,p′-DDT, although this association was weak.
Comparing the 75th to the 25th percentile, there was a 1.7-day increase in gestation length
with p,p′-DDT concentration and a 1.8-day increase with o,p′-DDT concentration. Some
heterogeneity by sex was observed for birth weight across all measures of DDT exposure
with males appearing to be more affected; however, the difference was small (data not
shown). Additional adjustment for PCB concentration did not substantially change the
results given in Table 3.
Five-Year Growth
Overall, few noteworthy associations were seen between the 4 measures of DDT and the 9
measures of growth at 5 years of age in either adjusted or unadjusted models. Results for
height, weight, and head circumference measures are given in Table 4. After adjusting for
maternal BMI, height, race, and quality of prenatal care (inadequate, adequate, intermediate,
or more than adequate45), head circumference was 2 mm greater among children at the 75th
percentile of p,p′-DDE concentration compared with children at the 25th percentile (95% CI
= 0 to 4). A similar association was also observed for Σ DDT. Estimates for biacromial
distance, chest breadth and depth, and bi-iliac distance were small and imprecise and
showed no important associations with any of the measures of DDT (data not shown). No
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consistent or noteworthy heterogeneity by child’s sex was observed in relation to DDT
exposure and 5-year growth. Similar to the fetal growth outcomes, additional adjustment for
PCB concentration did not alter our findings.
DISCUSSION
We found little evidence of associations between in utero DDT exposure in the ranges of
exposure studied and fetal and early childhood growth. Despite adjustment for maternal and
paternal factors, estimated effect sizes were small and imprecise, and there were no
consistent patterns of association across exposures or outcomes.
Four other major cohort studies13,15,33,48 have examined the association between in utero
DDT exposure and fetal growth with equivocal results. In 2 of these studies,15,48 DDT
concentrations were considerably lower than those in the current study and both found little
evidence of effects on fetal growth. In one of these, Rogan and colleagues48 measured
maternal body burden of p,p′-DDE in a cohort of 912 children born between 1978 and 1982
in North Carolina; like the current study, they found no association between p,p′-DDE levels
and either birth weight or head circumference. In another study with lower maternal DDT
exposures than the current study, Gladen and colleagues15 measured p,p′-DDE and p,p′-
DDT concentrations in 197 mothers giving birth between 1993 and 1994 to singleton infants
in the Ukraine. Although unadjusted models and those adjusted for gestational age showed
increasing birth weight with increasing maternal concentrations of p,p′-DDE, this
association disappeared after adjustment for other potential confounding factors such as
maternal age, height, and parity.
The other 2 cohort studies of note included mothers with DDT concentrations that were
similar to those in the current study.13,33 In a study of 2,380 children from the Collaborative
Perinatal Project, born between 1959 and 1966 in the United States, increasing maternal p,p
′-DDE concentrations were associated with an increased risk of preterm and small-for-
gestational-age birth.13 Specifically, the risk of pre-term birth was approximately 3 times
greater among mothers with p,p′-DDE serum concentrations of at least 60 μg/L compared
with mothers who had concentrations below 15 μg/L contrary to our results of increased
gestational age with increased concentrations of p,p′-DDT and o,p′-DDT. However, a
limitation of our study is that we selected infants who completed at least 35 weeks of
gestation. Therefore, our gestational age results are not directly comparable with those from
the Collaborative Perinatal Project.13
A study by Farhang and colleagues33 also selected mothers and infants from the same San
Francisco cohort on which we based our study. Their participants had been selected from an
earlier case–control study of male genital abnormalities within the cohort49 and so their
sample included only male infants. The authors noted that increases in maternal p,p′-DDE
and p,p′-DDT reduced the risk of small-for-gestational-age birth, although the estimates
were imprecise. We observed similar associations for p,p′-DDT and o,p′-DDT in relation to
gestational age at birth, although we had excluded infants less than 35 weeks gestation.
Overall, however, the study by Farhang and colleagues33 found little association between
measures of DDT and fetal growth as we observed in our data sampled from the same
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population. Some authors15 have suggested that differences in the magnitude of maternal
exposure may explain positive and negative study results with only high concentrations of
DDT exposure lowering birth weight. Our findings and those of Farhang and colleagues,
however, do not support this assertion, at least not at the exposure levels observed.
With regard to postnatal effects, few studies have examined DDT exposure in relation to
growth beyond infancy, and most have focused on anthropometric measures at puberty,24,25
making it difficult to compare our 5-year growth results with previous study findings. In the
North Carolina cohort, height and height-adjusted weight at puberty among boys showed a
positive association with transplacental exposures to p,p′-DDE.25 In the Collaborative
Perinatal Project,24 none of the prenatal measures of DDT compounds were associated with
height, ratio of sitting height to height, BMI, and skeletal age at puberty. We observed little
association between DDT exposures and height and weight at 5 years. Karmaus and
colleagues26 studied 343 German children to determine whether DDE concentrations
measured at 8 years of age were predictive of children’s growth from birth through 10 years
of age. In that study, growth in girls was inversely associated with exposure to DDE. This
association between DDE and growth was not observed when girls were examined at 10
years of age, however. Additionally, no association between DDE and growth was observed
among boys. However, any of these findings might well be biased, in an unknown direction,
by the use of an exposure measurement obtained at 8 years of age. In contrast, 5-year growth
was not associated with prenatal exposures to DDT in our study, and sex-specific
associations were not observed.
Several potential limitations of our study should be noted, particularly when interpreting our
null results. Data on postnatal exposures to DDT were not available, and thus we were
unable to assess the potential effects of both pre- and postnatal exposure on 5-year growth.
Information on breast-feeding was not systematically collected. However, few women
breastfed their infants in those years, limiting our ability to draw conclusions about potential
exposures from this source. To the extent that postnatal exposures in children were different
from prenatal exposures or acted differently on growth, our results at 5 years of age may
have been biased toward the null. On the other hand, the lack of multiple measures of in
utero exposure is unlikely to be a concern in terms of misclassification of maternal exposure
as a study of stored serum samples from the Collaborative Perinatal Project indicated that
p,p′-DDE concentrations were highly stable throughout pregnancy with correlation
coefficients of at least 0.82 between any 2 trimesters.50
Another limitation may involve our selection process, because we selected only women
whose pregnancies lasted at least 35 weeks. Thus, if the association between DDT and
growth is apparent only in more vulnerable preterm infants, our study could not have
detected such an association. Furthermore, there is some evidence that increasing maternal
DDT concentrations increase a woman’s risk of spontaneous abortion or early fetal
loss.51–53 Thus, by selecting only live births, we may be missing other adverse pregnancy
outcomes and are focusing attention on the healthy survivors.
The validity of our data is supported first by the confirmation of known risk factors for
IUGR (most notably maternal smoking, low maternal BMI, and female sex), and, second, by
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the comparability of our organochlorine concentrations to another sample of women taking
part in the CHDS33,49 and to other historical samples from a similar time period.13
In summary, we observed little association between in utero exposures to DDT and fetal and
early childhood growth. Sex-specific effects on fetal and early childhood growth were also
not observed despite examining several estrogenic and antiandrogenic DDT compounds. To
our knowledge, this is the first large study to examine in utero exposures to DDT in relation
to growth during childhood and to assess the relation between the estrogenic DDT isomer
o,p′-DDT and in utero growth.
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TABLE 2
Distributions of Fetal and Early Childhood Growth Outcomes and DDT Concentrations
Characteristic No. Mean ± SD Median 25th, 75th Percentile
DDT concentrations (lipid-adjusted, in μg/g lipid)
 p,p′-DDE 399 6.85 ± 4.80 5.88 3.90, 8.56
 p,p′-DDT 399 1.93 ± 1.25 1.61 1.11, 2.30
 o,p′-DDT 399 0.27 ± 0.22 0.20 0.12, 0.35
 Σ DDT 399 9.05 ± 5.60 7.95 5.68, 11.15
Fetal growth outcomes
 Birth weight (g) 399 3298 ± 448 3345 2977, 3600
 Gestational age-adjusted  birth weight (z-score) 399 −0.25 ± 0.88 −0.27 −0.91, 0.37
 Gestational age (d) 399 281 ± 12 281 272, 288
 Birth length (cm) 398 51.2 ± 2.5 50.8 49.5, 52.7
 Head circumference (mm) 397 339 ± 14 343 330, 349
Five-year growth outcomes
 Sitting height (cm) 399 60.4 ± 2.8 60.3 58.7, 62.3
 Standing height (cm) 397 110 ± 4 110 107, 113
 Sex- and race-standardized height (z-score) 398 49.7 ± 9.7 50 43, 56
 Sex- and race-standardized weight (z-score) 399 49.2 ± 9.2 48 43, 54
 Head circumference (mm) 389 510 ± 15 508 498, 521
 Biacromial distance (mm) 389 245 ± 16 246 236, 255
 Chest breadth (mm) 389 177 ± 9.0 176 170, 183
 Chest depth (mm) 389 135 ± 10.9 134 128, 142
 Bi-iliac distance (mm) 389 174 ± 10 174 167, 180
SD indicates standard deviation.
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